Evidence map›Paper›PMID 36180873›Full record

ArticleBMC health services research2022

Patient and health-care provider experience of a person-centred, multidisciplinary, psychosocial support and harm reduction programme for patients with harmful use of alcohol and drug-resistant tuberculosis in Minsk, Belarus.

Rebecca Elizabeth Harrison, Volha Shyleika, Christian Falkenstein, Ekaterine Garsevanidze, Olga Vishnevskaya, Knut Lonnroth, Öznur Sayakci, Animesh Sinha, Norman Sitali, Alena Skrahina and 8 more

Open access · goldAbstract read
In one paragraph

Article in BMC health services research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Observational
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 4 institutions in 4 countries.

Rebecca Elizabeth HarrisonMédecins Sans Frontières, Minsk, Belarus.
Volha ShyleikaMédecins Sans Frontières, Minsk, Belarus.
Christian FalkensteinMédecins Sans Frontières, Minsk, Belarus.
Ekaterine GarsevanidzeMédecins Sans Frontières, Minsk, Belarus.
Olga VishnevskayaMédecins Sans Frontières, Minsk, Belarus.
Knut LonnrothDepartment of Global Public Health, Karolinska Institutet, Stockholm, Sweden.
Öznur SayakciMédecins Sans Frontières, Minsk, Belarus.
Animesh SinhaMédecins Sans Frontières, London, UK.
Norman SitaliMédecins Sans Frontières, Berlin, Germany.
Alena SkrahinaRepublican Scientific and Practical Centre of Pulmonology and Tuberculosis (RSPCPT), Minsk, Republic of Belarus.
Beverley StringerMédecins Sans Frontières, London, UK.
Cecilio TanMédecins Sans Frontières, Moscow, Russia.
Htay Thet MarMédecins Sans Frontières, Minsk, Belarus.
Sarah VenisMédecins Sans Frontières, London, UK.
Dmitri VetushkoRepublican Scientific and Practical Centre of Pulmonology and Tuberculosis (RSPCPT), Minsk, Republic of Belarus.
Kerri VineyDepartment of Global Public Health, Karolinska Institutet, Stockholm, Sweden.
Raman VishneuskiMédecins Sans Frontières, Minsk, Belarus.
Antonio Isidro Carrion MartinMédecins Sans Frontières, London, UK. Isidro.carrion-martin@london.msf.org.
Médecins Sans Frontières‎ · GBRepublican Scientific and Practical Centre of Pulmonology and Tuberculosis · BYKarolinska Institutet · SEUniversity of Sydney · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTuberculosis (TB) often concentrates in groups of people with complex health and social issues, including alcohol use disorders (AUD). Risk of TB, and poor TB treatment outcomes, are substantially elevated in people who have AUD. Médecins sans Frontières and the Belarus Ministry of Health have worked to improve treatment adherence in patients with multi-drug or rifampicin resistant (MDR/RR)-TB and harmful use of alcohol. In 2016, a person-centred, multidisciplinary, psychosocial support and harm reduction programme delivered by TB doctors, counsellors, psychiatrists, health-educators, and social workers was initiated. In 2020, we described patient and provider experiences within the programme as part of a wider evaluation.

methodsWe recruited 12 patients and 20 health-care workers, using purposive sampling, for in-depth individual interviews and focus group discussions. We used a participant-led, flexible, exploratory approach, enabling participants and the interviewer to shape topics of conversation. Qualitative data were coded manually and analysed thematically. As part of the analysis process, identified themes were shared with health-care worker participants to enable their reflections to be incorporated into the findings.

resultsKey themes related to the patients' and practitioners experience of having and treating MDRTB with associated complex health and social issues were: fragility and despair and guidance, trust and health. Prejudice and marginalisation were global to both themes. Counsellors and other health workers built a trusting relationship with patients, enabling guidance through a multi-disciplinary approach, which supported patients to achieve their vision of health. This guidance was achieved by a team of social workers, counsellors, doctors and health-educators who provided professional and individualised help for patients' illnesses, personal or interpersonal problems, administrative tasks, and job searches.

conclusionsPatients with MDR/RR-TB and harmful use of alcohol faced complex issues during treatment. Our findings describe how person-centred, multi-disciplinary, psychosocial support helped patients in this setting to cope with these challenges and complete the treatment programme. We recommend that these findings are used to: i) inform programmatic changes to further boost the person-centred care nature of this program; and ii) advocate for this type of person-centred care approach to be rolled out across Belarus, and in contexts that face similar challenges.

Indexed as

AlcoholismTuberculosisTuberculosis, Multidrug-ResistantAntitubercular AgentsHarm ReductionHumansPsychosocial Support SystemsQualitative ResearchRepublic of BelarusRifampinAntitubercular AgentsRifampinAlcohol use disorderHarmful use of alcoholMDR/RR-TB (multi-drug or rifampicin resistant tuberculosis)Multi-disciplinaryPerson-centred

Identifiers

PMID36180873
PMCPMC9523183
OpenAlexW4298146916

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.